Welcome to our dedicated page for MacKenzie Realty Capital SEC filings (Ticker: MKZR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MacKenzie Realty Capital's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MacKenzie Realty Capital's regulatory disclosures and financial reporting.
Robert E. Dixon filed Amendment No. 3 to a Schedule 13D reporting beneficial ownership of 213,265 shares of MacKenzie Realty Capital, Inc. common stock, representing 7.69% of the 2,774,688 shares outstanding as of August 4, 2026.
He holds 54,241 shares (1.95%) with sole voting and dispositive power and may be deemed to share voting and investment power over an additional 159,024 shares held through MPF Successors, LP, MacKenzie Real Estate Advisers, LP, and Berniece Patterson Legacy Trust. Berniece Patterson Legacy Trust used $87,774.79 to purchase its shares, and Dixon expressly disclaims beneficial ownership of the partnership and trust holdings beyond any pecuniary interest.
MacKenzie Realty Capital, Inc. CEO/President Robert E. Dixon reported indirect purchase transactions totaling 66,600 common shares through Berniece Patterson Legacy Trust on July 31 and August 3, 2026, at weighted-average prices of $1.41 and $1.20 per share within disclosed price ranges.
The report also lists indirect positions of 86,855 shares via MacKenzie Real Estate Advisers, LP and 5,569 shares via MPF Successors, LP, plus 54,241 shares held directly; Dixon may be deemed to beneficially own these securities but disclaims beneficial ownership beyond his pecuniary interest.
MacKenzie Realty Capital, Inc. treasurer Glen W. Fuller reported indirect purchases totaling 66,600 shares of common stock in late July and early August 2026 through Berniece Patterson Legacy Trust, at weighted average prices of $1.41 and $1.20 per share.
The report also lists indirect post-transaction holdings of 86,855 shares via MacKenzie Real Estate Advisers, LP and 5,569 shares via MPF Successors, LP. Fuller is a beneficiary or interest holder in these entities and could be deemed to beneficially own the shares but disclaims beneficial ownership beyond his pecuniary interest; the transactions were not under a Rule 10b5-1 trading plan.
MacKenzie Realty Capital, Inc. director and General Counsel/Secretary Charles E. Patterson II reported indirect open‑market purchases of common stock through Berniece Patterson Legacy Trust: 36,600 shares on July 31, 2026 at a weighted‑average $1.41 and 30,000 shares on August 3, 2026 at a weighted‑average $1.20, executed in multiple trades within disclosed price ranges of $1.21–$1.50 and $1.10–$1.29. He is a beneficiary of this trust and holds interests in partnerships reporting 86,855 and 5,569 shares, and in each case disclaims beneficial ownership except to the extent of his pecuniary interests.
MacKenzie Realty Capital, Inc. reports on a tender offer for shares of National Healthcare Properties, Inc. (NHP). The company is under contract to purchase over $1,000,000 in NHP shares at $7.27 per share, and increased the offer size from 150,000 to 300,000 shares. It has begun purchasing approximately 140,000 shares and plans to fund the transaction through an additional loan agreement with Streeterville Capital on terms similar to prior notes. With free-trading NHP shares having closed at $16.08 per share, management cites an unrealized gain of over $1,200,000 that could be realized when the NHP shares become freely tradeable in October, assuming the stock price remains at that level.
Operationally, Aurora at Green Valley, a recently completed multifamily development, is now 100% leased, with net operating income ahead of projections. In addition, wholly owned subsidiary MacKenzie Apartment Communities, Inc. declared and paid its first dividend to MacKenzie of $0.045 per share for the quarter ending June 30, 2026.
MacKenzie Realty Capital, Inc. has detailed quarterly dividends for its Series A, Series B and Series C preferred shares, all payable to holders of record as of June 30, 2026. The communication also describes dividend rates the board has approved for upcoming preferred share record dates through September 30, 2026, with payment in October 2026.
For Series A, investors accepted as of April 1 or earlier receive $0.375 per share (6% annualized), with $0.25 for May 1 acceptances and $0.125 for June 1; the board approved further Series A dividends of $0.125 per share per month for July 31, August 31 and September 30 record dates. Series B preferred shares carry a 12% preferred return on the $25 purchase price, split between cash dividends of $0.75 per share per year ($0.0625 per month) and accrued returns of $2.25 per year ($0.1875 per month). Series C preferred shares provide a 9% preferred return, or $2.25 per share per year, equating to $0.1875 per month, with similar July–September record dates and October payment timing.
MacKenzie Realty Capital reported much stronger results for the fiscal third quarter ended March 31, 2026. Net revenues rose to $5.4 million, up 27% from $4.3 million a year earlier. Net loss narrowed sharply to $1.0 million from $6.1 million.
The company moved back into positive cash-based performance measures, posting FFO of $308,040 versus negative $3.2 million and AFFO of $537,514 versus negative $2.3 million. Aurora at Green Valley is now stabilized and over 90% leased, and a CNL Healthcare investment generated a $521,718 profit, with related debt repaid.
MacKenzie Realty Capital reported a much stronger fiscal third quarter for the period ended March 31, 2026. Net revenues rose to $5.4 million, up 27% from $4.3 million a year earlier. Net operating loss narrowed to $2.5 million from $5.8 million, while net loss improved to $1.0 million from $6.1 million, an 84% reduction.
Funds from operations (FFO) turned positive at $308,040 versus a $3.2 million deficit, and adjusted FFO (AFFO) improved to $537,514 from negative $2.3 million, reflecting better cash-style performance. The Company also highlighted that its Aurora at Green Valley property is now stabilized and over 90% leased, and it realized a $521,718 profit on a CNL Healthcare Properties investment financed with a short-term Streeterville Capital loan that has been paid down.
MacKenzie Realty Capital, Inc. reports higher rental and property income but remains unprofitable. For the quarter ended March 31, 2026, rental, reimbursement and other property income was $5,441,504, up from $4,273,646 a year earlier, yet operating expenses kept results negative.
Quarterly net loss attributable to common stockholders improved to $2,044,591 from $6,911,399, and nine‑month net loss was $11,637,478. Total assets were $239,440,124 and total liabilities $154,183,226, leaving total equity of $85,256,898. Operating cash flow for the nine months was a use of $2,755,870, funded largely by new debt and equity financing.
MacKenzie Realty Capital, Inc. has confirmed regular dividends for its Series A, B and C preferred shares for the quarter ending June 30, 2026. The update explains current quarterly payments and sets monthly dividend rates for April, May and June, payable in July 2026.
Series A investors of record on March 31, 2026 receive up to $0.375 per share for the quarter, with lower amounts for later acceptance dates, and a newly approved $0.125 per share monthly dividend. Series B pays a 12% preferred return on the $25 purchase price, split between cash and accrued dividends, with $0.0625 per share in monthly cash dividends approved. Series C provides a 9% preferred return, or $0.1875 per share per month, with that monthly rate approved for April through June 2026.